Lilly's Struggle To Come Back: Can Once-Great Pharma Companies Be Great Again?

Note: The following blog was written before the cancellation of Lilly’s high-profile evacetrapib program announced this morning (10/12/15). This unfortunate setback validates the concerns expressed below.